X

Health Care

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary

Trxade Health, Inc. (NASDAQ: MEDS) operates as an integrated drug procurement and delivery platform, focused on digitalizing the retail pharmacy…

Earnings Summary: Baxter International reports higher Q4 sales and adj. profit

Medical device maker Baxter International Inc. (NYSE: BAX) has announced financial results for the fourth quarter of 2023, reporting higher…

CVS Health Q4 2023 adj. earnings rise on higher revenues; guides FY24

Healthcare conglomerate CVS Health Corporation (NYSE: CVS) announced fourth-quarter 2023 results, reporting higher revenues and adjusted earnings. December quarter adjusted…

Earnings Summary: Highlights of Centene Corp’s Q4 2023 financial results

Healthcare service provider Centene Corporation (NYSE: CNC) on Tuesday announced fourth-quarter 2023 results, reporting an increase in revenues and a…

Earnings: Highlights of Eli Lilly & Company’s (LLY) Q4 2023 results

Eli Lilly and Company (NYSE: LLY) on Tuesday reported double-digit growth in revenues and adjusted earnings for the fourth quarter…

Earnings Summary: Everything you need to know about IDEXX’s Q4 2023 report

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a provider of pet healthcare innovation, on Monday reported higher revenues and net income for…

Infographic: How Bristol Myers Squibb (BMY) performed in Q4 2023 financial results

Bristol Myers Squibb (NYSE: BMY) reported fourth quarter 2023 earnings results today. Total revenues inched up 1% to $11.5 billion…

ABBV Earnings: Everything you need to know about AbbVie’s Q4 report

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…

Eli Lilly and Company all set to report Q4 results. Here’s what to expect

Pharmaceutical company Eli Lilly and Company (NYSE: LLY) is preparing to report fourth-quarter earnings. In recent years, the drugmaker successfully…

MRK Earnings: Highlights of Merck’s Q4 2023 financial results

Pharmaceutical company Merck & Co. Inc. (NYSE: MRK) reported a sharp fall in adjusted earnings for the fourth quarter of…